Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insect voltage-gated calcium channels (VGCCs) are essential transmembrane proteins that facilitate the entry of calcium ions into excitable cells upon membrane depolarization. In insects, these channels are typically encoded by three primary genes for the alpha1 subunit, corresponding to the CaV1 (L-type), CaV2 (non-L-type), and CaV3 (T-type) families found in vertebrates (ResearchGate, 2024; NIH, 2007). They serve as critical transducers that convert electrical impulses into intracellular chemical signals, driving vital processes such as synaptic vesicle exocytosis, muscle contraction, and gene regulation (Wikipedia, 2024; ENS Lyon, 2012). Due to their central role in the insect nervous and muscular systems, VGCCs are significant targets for pest control strategies. While many conventional insecticides like pyrethroids and organophosphates primarily target sodium channels or acetylcholinesterase, they often exert secondary inhibitory effects on VGCCs, contributing to their overall neurotoxicity (NIH, 2014; Toxicological Sciences, 2014). Furthermore, novel bioinsecticides derived from spider and snail venoms, such as ω-agatoxins and ω-Atyptoxins, specifically block these channels to induce rapid paralysis in prey (NIH, 2024). A major challenge in the development of VGCC-targeted agents is ensuring high selectivity for insect isoforms over mammalian counterparts to minimize human health risks and protect non-target beneficial insects (ENS Lyon, 2012; ResearchGate, 2014).
Inhibition of calcium ion influx through the pore-forming alpha1 subunit, which disrupts the coupling of electrical signals to physiological responses such as neurotransmitter release and muscle contraction (ResearchGate, 2024; ENS Lyon, 2012).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insect voltage-gated calcium channels (VGCCs).